Loading…
Shukra Pharmaceuticals (SHUKRAPHAR)₹82.05+0.58%Pharmaceuticals
At the end of the Sep 2026 quarter, Shukra Pharmaceuticals' shareholders were: promoters 51.20%, DIIs 0.11%, public 48.69%. Promoter holding is up 0.21 percentage points from 50.99% a quarter earlier. 0.00% of promoter shares were pledged. It had 28,391 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.99% | 50.99% | 50.99% | 50.99% | 50.99% | 50.99% | 50.99% | 50.99% | 50.99% | 50.99% | 50.99% | 51.20% |
| DIIs | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Public | 48.90% | 48.90% | 48.90% | 48.90% | 48.90% | 48.90% | 48.90% | 48.90% | 48.90% | 48.90% | 48.90% | 48.69% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 10,966 | 12,977 | 14,993 | 16,325 | 17,848 | 18,235 | 20,342 | 21,446 | 25,655 | 27,179 | 28,391 | 28,391 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Renuka Yogesh Parikh | Public | 19.15% | −0.07 |
| Yogesh Biharilal Parikh | Public | 19.03% | −0.08 |
| Anar Project Private Limited | Promoter | 18.73% | −0.07 |
| Parshva Texchem India Private Ltd. | Promoter | 17.39% | +0.21 |
| Navkar Surgical Gujarat Limited | Promoter | 11.78% | −0.04 |
| Dakshesh Rameshchandra Shah | Promoter | 1.10% | +0.11 |
| Anar Jayeshbhai Patel | Promoter | 1.00% | −0.01 |
| Sujay Jyotindra Mehta | Promoter | 0.71% | 0.00 |
| Payal Sujay Mehta | Promoter | 0.53% | 0.00 |
Promoters held 51.20% of Shukra Pharmaceuticals at the end of the Sep 2026 quarter, up 0.21 percentage points from 50.99% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.11% (unchanged at 0.11% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Shukra Pharmaceuticals had 28,391 shareholders at the end of the Sep 2026 quarter, against 21,446 a year earlier.
Renuka Yogesh Parikh (Public) held 19.15% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.